# Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency

> **NCT02594904** · PHASE4 · UNKNOWN · sponsor: **Southern Medical University, China** · enrollment: 300 (estimated)

## Conditions studied

- Neonatal Hyperbilirubinemia

## Interventions

- **DRUG:** Yinzhihuang Oral Liquid

## Key facts

- **NCT ID:** NCT02594904
- **Lead sponsor:** Southern Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2016-04
- **Final completion:** 2016-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594904, "Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02594904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*